Genix Pharmaceuticals Corporation
GENX.V
TSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -222.70K | -202.00K | -239.40K | -60.10K | -59.30K |
| Total Depreciation and Amortization | -- | -- | -- | -600.00 | -400.00 |
| Total Amortization of Deferred Charges | 400.00 | 600.00 | 800.00 | 1.40K | 1.20K |
| Total Other Non-Cash Items | 137.90K | 114.80K | 128.00K | -79.20K | -86.00K |
| Change in Net Operating Assets | 16.40K | 21.70K | 23.50K | 44.30K | 28.10K |
| Cash from Operations | -68.00K | -64.80K | -86.90K | -94.10K | -116.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 42.10K | 32.50K | 87.30K | 127.80K | 158.40K |
| Total Debt Repaid | -30.00K | -30.00K | -30.00K | -- | -- |
| Issuance of Common Stock | 100.00K | 100.00K | 100.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.10K | -1.10K | -1.10K | -- | -- |
| Cash from Financing | 80.40K | 72.90K | 111.50K | 91.60K | 113.90K |
| Foreign Exchange rate Adjustments | -7.90K | -1.30K | -1.30K | -1.30K | -1.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.50K | 6.80K | 23.30K | -3.90K | -3.60K |